Literature DB >> 27704201

Technical feasibility and tissue reaction after silicone-covered biodegradable magnesium stent insertion in the oesophagus: a primary study in vitro and in vivo.

Yue-Qi Zhu1, Laura Edmonds2,3, Li-Ming Wei1, Rei-La Zheng2, Ruo-Yu Cheng2, Wen-Guo Cui4, Ying-Sheng Cheng5.   

Abstract

OBJECTIVES: Determine the feasibility of and tissue response to biodegradable magnesium-silicone stent insertion into the oesophagus of rabbits.
METHODS: Mechanical compression-recovery and degradation behaviours of the stents were investigated in vitro. Thirty rabbits were randomly divided into a magnesium-silicone stent group (n = 15) that received stent insertion into the lower 1/3 of the oesophagus under fluoroscopic guidance and a control group (n = 15). Oesophagography was performed at 1, 2 and 4 weeks. Five rabbits in each group were euthanized at each time point for histological examination.
RESULTS: Magnesium-silicone stents showed good flexibility and elasticity, and degraded more slowly than bare stents at pH 4.0 and 7.4. All stent insertions were well tolerated. The oesophageal diameters at 1, 2 and 4 weeks were 9.7 ± 0.7, 9.6 ± 0.8 and 9.6 ± 0.5 mm, respectively (vs. 9.2 ± 0.8 mm before intervention; P > 0.05). Stent migration occurred in six rabbits (one at 1 week, one at 2 and four at 4). Microscopy demonstrated dilation of the oesophageal wall within 1 week of insertion. Oesophageal injury and collagen deposition following stent insertion were similar to control (P > 0.05).
CONCLUSIONS: Oesophageal magnesium-silicone stent insertion was feasible and provided reliable support for 2 weeks without causing oesophageal injury or collagen deposition. KEY POINTS: • Mg stent provided apparently adequate radial force and silicone membrane reduced magnesium biodegradation • Stent insertion provided good support for at least 2 weeks before biodegradation • Stenting effectively resulted in oesophageal wall remodelling, without demonstrable injury.

Entities:  

Keywords:  Biodegradation; Interventional radiology; Magnesium; Oesophagus; Stent

Mesh:

Substances:

Year:  2016        PMID: 27704201     DOI: 10.1007/s00330-016-4602-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  22 in total

1.  Tissue hyperplasia following placement of a biodegradable stent for a refractory esophageal stricture: treatment with argon plasma coagulation.

Authors:  F L Dumoulin; D Plassmann
Journal:  Endoscopy       Date:  2012-09-25       Impact factor: 10.093

2.  Self-expanding metallic stents and self-expanding plastic stents in the palliation of malignant oesophageal dysphagia.

Authors:  Heng Boon Yim
Journal:  Ann Palliat Med       Date:  2014-04

3.  Esophageal reconstitution by simultaneous antegrade/retrograde endoscopy: re-establishing patency of the completely obstructed esophagus.

Authors:  D Schembre; J B Dever; M Glenn; S Bayles; J Brandabur; R Kozarek
Journal:  Endoscopy       Date:  2011-02-28       Impact factor: 10.093

4.  In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia.

Authors:  R Kornowski; M K Hong; F O Tio; O Bramwell; H Wu; M B Leon
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

5.  Biodegradable rapamycin-eluting nano-fiber membrane-covered metal stent placement to reduce fibroblast proliferation in experimental stricture in a canine model.

Authors:  Y Q Zhu; W G Cui; Y S Cheng; J Chang; N W Chen; L Yan; M H Li
Journal:  Endoscopy       Date:  2013-04-11       Impact factor: 10.093

6.  Stent-associated esophagorespiratory fistulas: incidence and risk factors.

Authors:  Benjamin L Bick; Louis M Wong Kee Song; Navtej S Buttar; Todd H Baron; Francis C Nichols; Fabien Maldonado; David A Katzka; Felicity T Enders; Mark D Topazian
Journal:  Gastrointest Endosc       Date:  2012-12-11       Impact factor: 9.427

7.  Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial.

Authors:  Michael Haude; Raimund Erbel; Paul Erne; Stefan Verheye; Hubertus Degen; Dirk Böse; Paul Vermeersch; Inge Wijnbergen; Neil Weissman; Francesco Prati; Ron Waksman; Jacques Koolen
Journal:  Lancet       Date:  2013-03-09       Impact factor: 79.321

8.  Evaluation of biodegradable paclitaxel-eluting nanofibre-covered metal stents for the treatment of benign cardia stricture in an experimental model.

Authors:  Y-Q Zhu; W-G Cui; Y-S Cheng; J Chang; N-W Chen; L Yan
Journal:  Br J Surg       Date:  2013-05       Impact factor: 6.939

9.  Newly developed biodegradable stents for benign gastrointestinal tract stenoses: a preliminary clinical trial.

Authors:  Toyohiko Tanaka; Masashi Takahashi; Norihisa Nitta; Akira Furukawa; Akira Andoh; Yasuharu Saito; Yoshihide Fujiyama; Kiyoshi Murata
Journal:  Digestion       Date:  2007-03-06       Impact factor: 3.216

10.  Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study.

Authors:  Alessandro Repici; Frank P Vleggaar; Cesare Hassan; Petra G van Boeckel; Fabio Romeo; Nicola Pagano; Alberto Malesci; Peter D Siersema
Journal:  Gastrointest Endosc       Date:  2010-11       Impact factor: 9.427

View more
  3 in total

1.  Micro-endoscopy for Live Small Animal Fluorescent Imaging.

Authors:  Bjorn Paulson; Jun Ki Kim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Updates on the research and development of absorbable metals for biomedical applications.

Authors:  Hendra Hermawan
Journal:  Prog Biomater       Date:  2018-05-22

3.  Translational status of biomedical Mg devices in China.

Authors:  Yu Sun; Hongliu Wu; Wenhui Wang; Rui Zan; Hongzhou Peng; Shaoxiang Zhang; Xiaonong Zhang
Journal:  Bioact Mater       Date:  2019-11-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.